Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Prognostic value of D-dimer and troponin I in submassive pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004
Prognostic value of troponin I in patients with non-massive acute pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality Source: Annual Congress 2006 - Pulmonary embolism Year: 2006
C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
D-dimer is of limited value in the diagnosis of pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Prognostic value of two clinical scores in patients with acute symptomatic pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
The diagnostic value of serum procalcitonin in differential diagnosis of pulmonary embolism and pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 462s Year: 2007
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Diagnostic value of d-dimer in the diagnosis of pulmonary embolism in pregnancy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010